Solving MedTech Regulatory Challenges | SGInnovate
January102019

Location

SGInnovate
32 Carpenter Street
Singapore 059911

Solving MedTech Regulatory Challenges

Presented by SGInnovate. Partnered With Asia Regulatory Professional Association

The MedTech industry is a highly regulated sector. As such, understanding how to navigate the regulatory system is a critical success factor. It is necessary to determine whether one’s medical device meets the regulatory requirements and whether there is a market for the technology. By having a smart strategy in meeting the regulatory standards, you would be able to launch your product quicker into the market. In this event, we will be going through ways to solve the challenges faced by prospective MedTech companies in ensuring their products meet the regulatory standards.

 

Date: 10 January 2019, Thursday
Time: 5.30pm to 7.30pm
Venue: 32 Carpenter Street, Singapore 059911

 

Speakers’ List:

  • Jack Wong, Founder, ARPA (Asia Regulatory Professional Association)
  • Prusothman Sina Raja, CEO & Co-Founder, Privi Medical Ptd Ltd 
  • Mark Chong, Senior Lecturer, Nanyang Technological University
  • May Ng, Global Director, ARQon (Asia Regulatory & Quality Consultancy) 

 

Programme Details:
5:30pm – 6:00pm: Registration
6:00pm – 7:00pm: Solving MedTech Regulatory Challenges and Q&A
7:00pm – 7:30pm: Networking

 

Speakers’ Profiles:

Jack Wong, Founder, Asia Regulatory Professional Association, Six Sigma Black Belt certified by IASSC

Jack Wong has over 20 years of Regulatory, Quality, Clinical Trial and Pharmacovigilance experience in Asia, and good knowledge in the field of Medical Devices, Pharmaceuticals, Nutritional, Consumer Healthcare and Biological products. 

He has received awards on improving processes such as reducing the time taken to launch a product by 20%, and for helping in developing people as shown by the Watson Wyatt Survey taken by all direct reporting staff which has indicated that 100% of them are able to contribute to their fullest ability.

Externally, he has a leading role among all the Regional Regulatory professionals in Asian Harmonization Working Party (AHWP). He developed the First Asia Regulatory Affairs Certificate course since 2007, with over 2800 students from the industry, government agencies and universities. As the founder of Asia Regulatory Professional Associations (ARPA) since 2010, with over 3600 members, Jack Wong has wrote the first Asia Regulatory Book in Asia – the ‘Handbook of Medical Device Regulatory Affairs in Asia’, which is on its 2nd edition as of now.

Jack is a Qualified Auditor of ISO 13485, Japanese Regulations for Medical Devices and ISO 9000 Lead Auditor by British Standards Institution.

 

Prusothman Sina Raja, Co-Founder, Privi Medical
 
Prusothman is the co-founder of Privi Medical, a medical device startup company spun out of Singapore-Stanford Biodesign (SSB). Prusothman has overseen Privi Medical’s rapid progress from concept to a regulatory cleared medical device. 

Apart from Privi, Prusothman has been directly involved in the development of a number of other healthcare and life sciences products. Prusothman was named a Forbes 30 Under 30 Asia for Healthcare and Science in 2017. 

Prusothman also previously served as the Assistant Fellowship Head of the Singapore-Stanford Biodesign Fellowship Program. Prusothman was a 2014 Singapore-Stanford Biodesign Innovation Fellow.

 

Mark Chong, Senior Lecturer, Nanyang Technological University

Dr Mark Chong obtained his PhD in Bioengineering from the National University of Singapore in 2010. He then joined the National University Health System as a Research Fellow, where he was part of the team working on translational regenerative medicine projects, including clinical trials for stem cell therapeutics. 

He is currently a senior lecturer in the Nanyang Technological University, where he also serves as Assistant Chair in the School of Chemical and Biomedical Engineering, facilitating talent development for the Medical Device industry. 

In 2017, Mark undertook the Singapore-Stanford Biodesign Fellowship while on sabbatical, and now contributes time as co-curriulum head for Singapore Biodesign, where he develops training and reference material for MedTech Innovation in Asia.

May Ng, Global Director, ARQon (Asia Regulatory & Quality Consultancy) 


May Ng is the Global Director of ARQon, Asia Regulatory & Quality Consultancy for medical devices and drugs, assisting company in product development and product registration in Asia, global approval and CE Representative. ARQon present globally with offices in Singapore, Vietnam, Malaysia, Taiwan, Switzerland and with partners worldwide.

Ms. Ng was in Singapore Health Sciences Authority (HSA) for almost 10 years to complete the implementation of the Singapore regulatory framework based on IMDRF/GHTF principles, and approving medical device/IVD. She joined Biosensors drug coated stent manufacturing in Singapore for 4 years and previous 2 years in IVD industry.

Currently, she holds role as the Advisor for the government organizations such as NHIC, ETPL, NUS and main committee in Singapore Manufacturing Federation’s MedTech Industry Group, China-ASEAN Medical and the Singapore representative in the early year 1999 for the formation of AHWP and ASEAN-MDPWG for ASEAN Medical Device Directive.

Topics: MedTech / HealthTech / BioTech

You may also like the following:

  • Real Successes and Applications of Digital Health

    With levels of investments that have never been seen before (billions of dollars and counting), Digital Health is now moving faster than ever and every player in the industry needs to include it in their corporate strategies – from pharma companies to insurers, even brick and mortar hospital chains. However, the maturity level of corporates varies greatly, which dramatically impacts the success of the digitisation process in these organisations. During this fireside chat, industry veterans François Cadiou and Julien de Salaberry will share about the latest successes observed in Digital Health and how the stakeholders involved, from the corporates to the startups, manage to make it a success.

    Topics:

    MedTech / HealthTech / BioTech

  • Investors Night: MedTech

    With the success of our first Investors Night: Medtech, we will be organising the follow-up to the series this March.

    Topics:

    MedTech / HealthTech / BioTech

  • Reimbursement of Innovative Health Technologies

    A challenge for many health tech startups is pricing their products with a multitude of payers – insurance companies, governments, and hospital systems – in mind. 

    Topics:

    MedTech / HealthTech / BioTech

  • Corporate – Startup Collaborations in MedTech

    Today, Singapore hosts more than 200 MedTech SMEs and startups, and over 60 multinational medtech firms that undertake activities from regional headquarters and manufacturing to research and development. These companies continue to provide tangible benefits for Singapore's research, innovation and enterprise and healthcare systems, and well position Singapore to serve the larger Asian marketplace. 

    Topics:

    MedTech / HealthTech / BioTech, Startups

  • Rising Stars in HealthTech: Data and Artificial Intelligence

    SGInnovate, General Assembly and Galen Growth Asia are teaming up for a series of events with some of the most inspiring Southeast Asian healthtech founders and leaders. In a candid discussion, they will share their stories and insights on:

    Topics:

    MedTech / HealthTech / BioTech

  • Guest Writer

    Helping AI Embrace Empathy

    Artificial intelligence is already a part of our everyday lives, but for it to truly make a difference it needs to understand human emotions, says Live with AI founder Pierre Robinet.

    This article is written by Pierre Robinet, who is a senior consulting partner at Ogilvy Consulting and founder of Live With AI, an independent think tank based in Singapore.

    Topics: A.I., MedTech, Data Science / Data Analytics, Others